Clinical Trial Update: Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the efficacy, safety, and tolerability of eslicarbazepine acetate for preventing recurrence in Bipolar I Disorder; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zebinix (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Bipolar I Disorder | Phase 2 | Status: COMPLETED | Results posted: 2013-06-17